Up a level |
Chai, Chee Shee and Liam, Chong Kin and Lin, O. Po and Pang, Yong Kek and Ho, G. F. and Alip, A. and Wong, C. K. and Poh, M. E. (2019) Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma. Annals of oncology, 30 (9). p. 164. ISSN 0923-7534